Annals of the Rheumatic Diseases: 79 (4)

Heroes and pillars of rheumatology

Gerald Weissmann: Inflammation in rheumatic disease (22 January, 2020)
Bruce N Cronstein, Jill P Buyon, Steven B Abramson

Viewpoint

What is the real role of ultrasound in the management of juvenile idiopathic arthritis? (14 February, 2020)
Rolando Cimaz, Teresa Giani, Roberto Caporali

Rheumatoid arthritis

Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014 (17 February, 2020)
Elena Myasoedova, John Davis, Eric L Matteson, Cynthia S Crowson
Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal? (5 February, 2020)
Paul Studenic, David Felson, Maarten de Wit, Farideh Alasti, Tanja A Stamm, Josef S Smolen, Daniel Aletaha
Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM) (24 February, 2020) Free
Sofia Ramiro, Robert BM Landewé, Désirée van der Heijde, Alexandre Sepriano, Oliver FitzGerald, Mikkel Ostergaard, Joanne Homik, Ori Elkayam, J Carter Thorne, Margaret Larche, Gianfranco Ferraciolli, Marina Backhaus, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G Cantagrel, Cornelia F Allaart, Cheryl Barnabe, Clifton O Bingham, Paul P Tak, Dirkjan van Schaardenburg, Hilde Berner Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P Maksymowych
Effect on efficacy and safety trial outcomes of also enrolling patients on ongoing glucocorticoid therapy in rheumatoid arthritis clinical trials of tocilizumab or adalimumab or methotrexate monotherapy (7 February, 2020)
Mary Safy-Khan, Johannes W G Jacobs, Maria J H de Hair, Paco M J Welsing, Michael D Edwardes, Xavier M Teitsma, Yves Luder, Jenny Devenport, Jacob M van Laar, Attila Pethoe-Schramm, Johannes W J Bijlsma
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial (29 January, 2020)
Paul Emery, Sarah Horton, Raluca Bianca Dumitru, Kamran Naraghi, Désirée van der Heijde, Richard J Wakefield, Elizabeth M A Hensor, Maya H Buch
Antibodies and B cells recognising citrullinated proteins display a broad cross-reactivity towards other post-translational modifications (10 February, 2020)
T Kissel, S Reijm, LM Slot, M Cavallari, CM Wortel, RD Vergroesen, G Stoeken-Rijsbergen, JC Kwekkeboom, ASB Kampstra, EWN Levarht, JW Drijfhout, H Bang, KM Bonger, GMC Janssen, PA van Veelen, TWJ Huizinga, HU Scherer, M Reth, REM Toes
Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling (24 February, 2020)
Lars Godmann, Miriam Bollmann, Adelheid Korb-Pap, Ulrich König, Joanna Sherwood, Denise Beckmann, Katja Mühlenberg, Frank Echtermeyer, James Whiteford, Giulia De Rossi, Thomas Pap, Jessica Bertrand

Psoriatic arthritis

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis (19 March, 2020)
Elsa Vieira-Sousa, Pedro Alves, Ana M Rodrigues, Filipa Teixeira, Jose Tavares-Costa, Alexandra Bernardo, Sofia Pimenta, Fernando M Pimentel-Santos, João Lagoas Gomes, Renata Aguiar, Patrícia Pinto, Taciana Videira, Cristina Catita, Helena Santos, Joana Borges, Graça Sequeira, Célia Ribeiro, Lídia Teixeira, Pedro Ávila- Ribeiro, Fernando M Martins, Helena Canhão, Iain B. McInnes, Ruy M Ribeiro, João Eurico Fonseca
Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis (20 February, 2020)
Margarida Souto-Carneiro, Lilla Tóth, Rouven Behnisch, Konstantin Urbach, Karel D Klika, Rui A Carvalho, Hanns-Martin Lorenz

Systemic sclerosis

Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH (10 February, 2020)
Christopher W Wasson, Giuseppina Abignano, Heidi Hermes, Maya Malaab, Rebecca L Ross, Sergio A Jimenez, Howard Y Chang, Carol A Feghali-Bostwick, Francesco del Galdo

Sjögren’s syndrome

Elevated EPSTI1 promote B cell hyperactivation through NF-κB signalling in patients with primary Sjögren’s syndrome (29 February, 2020)
Jin-lei Sun, Hao-ze Zhang, Su-ying Liu, Chao-feng Lian, Zhi-lei Chen, Ti-hong Shao, Shuo Zhang, Li-ling Zhao, Cheng-mei He, Mu Wang, Wen Zhang, Hua Chen, Feng-chun Zhang

Osteoarthritis

Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial (25 February, 2020)
Felix Eckstein, Jeffrey L Kraines, Aida Aydemir, Wolfgang Wirth, Susanne Maschek, Marc C Hochberg

Crystal arthropathies

Hypersensitivity reactions with allopurinol and febuxostat: a study using the Medicare claims data (5 February, 2020)
Jasvinder A. Singh, John D. Cleveland
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of gout (29 February, 2020)
Viola Klück, Rosanne C van Deuren, Giulio Cavalli, Amara Shaukat, Peer Arts, Maartje C Cleophas, Tania O Crișan, Anne-Kathrin Tausche, Philip Riches, Nicola Dalbeth, Lisa K Stamp, Jennie Harré Hindmarsh, Tim L Th A Jansen, Matthijs Janssen, Marloes Steehouwer, Stefan Lelieveld, Maartje van de Vorst, Christian Gilissen, Lorenzo Dagna, Frank L Van de Veerdonk, Elan Z Eisenmesser, SooHyun Kim, Tony R Merriman, Alexander Hoischen, Mihai G Netea, Charles A Dinarello, Leo AB Joosten

Letters

Not only synovitis but also tenosynovitis needs to be considered: why it is time to update textbook images of rheumatoid arthritis (19 December, 2019)
Cleo Rogier, Silvia Hayer, Annette van der Helm-van Mil
Retinal vasculometric characteristics and their associations with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Eye Study (29 November, 2019)
Max Yates, Roshan Welikala, Alicja Rudnicka, Tunde Peto, Alexander J MacGregor, Anthony Khawaja, Richard Watts, David Broadway, Shabina Hayat, Robert Luben, Sarah Barman, Christopher Owen, Kay-Tee Khaw, Paul Foster
Dupilumab as a novel steroid-sparing treatment for IgG4-related disease (19 December, 2019)
Rachel S Simpson, Stephanie Ka Ching Lau, Jason Kihyuk Lee

Electronic pages

‘To switch or not to switch’: the missing piece in the puzzle of biosimilar literature? (4 January, 2019) Free
Marc Scherlinger, Thierry Schaeverbeke
Response to ‘‘To switch or not to switch’: the missing piece in the puzzle of biosimilar literature?’ by Scherlinger et al
(23 January, 2019) Free
Bente Glintborg, Anne Gitte Loft, Emina Omerovic, Oliver Hendricks, Asta Linauskas, Jakob Espesen, Kamilla Danebod, Dorte Vendelbo Jensen, Henrik Nordin, Emil Barner Dalgaard, Stavros Chrysidis, Salome Kristensen, Johnny Lillelund Raun, Hanne Lindegaard, Natalia Manilo, Susanne Højmark Jakobsen, Inger Marie Jensen Hansen, Dorte Dalsgaard Pedersen, Inge Juul Sørensen, Lis Smedegaard Andersen, Jolanta Grydehøj, Frank Mehnert, Niels Steen Krogh, Merete Lund Hetland
When binary and continuous responses disagree (25 January, 2019) Free
Fengchen Ouyang
Response to: ‘When binary and continuous responses disagree’ by Dr Ouyang (30 January, 2019) Free
Kim Lauper, Delphine Sophie Courvoisier, Cem Gabay
Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis (30 January, 2019) Free
Zachary Scott Wallace, Hyon Choi, John H Stone
Response to: ‘Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis’ by Wallace et al
(30 January, 2019) Free
Andreas Kronbichler, Julia Kerschbaum
Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis (1 February, 2019) Free
Maurizio Cutolo, Stefano Soldano, Sabrina Paolino
Response to: ‘Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis’ by Cutolo et al
(12 February, 2019) Free
Susan Aungier, Alison J Cartwright, Anja Schwenzer, Jennifer Marshall, Mike R Dyson, Peter Slavny, Kothai Parthiban, Aneesh Karatt-Vellatt, Ilfita Sahbudin, Eric Culbert, Patrick Hextall, Felix IL Clanchy, Richard Williams, Brian D Marsden, Karim Raza, Andrew Filer, Christopher D Buckley, John McCafferty, Kim S Midwood
Clinical trial and ‘real-world’ data support switching from a bio-originator to its biosimilar (18 January, 2019) Free
Jonathan Kay, Thomas Dörner, Paul Emery, Tore K Kvien, Ferdinand C Breedveld
‘Everything we see is a perspective, not the truth’ (13 February, 2019) Free
Arghya Chattopadhyay, Varun Dhir, Sanjay Jain
Response to ‘Everything we see is a perspective, not the truth’ by Chattopadhyay et al
(13 February, 2019) Free
Anna Molto, Julie Sahuguet, Jacques Fechtenbaum, Adrien Etcheto, Clementina López-Medina, Pascal Richette, Maxime Dougados, Christian Roux, Karine Briot
IgA vasculitis in adults: few certainties and many uncertainties (5 January, 2019) Free
Alojzija Hočevar, Matija Tomšič, Žiga Rotar
Response to ‘IgA vasculitis in adults: few certainties and many uncertainties’ by Hočevar et al
(30 January, 2019) Free
Alexander Tracy, Anuradhaa Subramanian, Nicola J Adderley, Lorraine Harper, Krishnarajah Nirantharakumar

Main menu

Table of contents

April 2020 - Volume 79 - 4

Heroes and pillars of rheumatology

Viewpoint

Rheumatoid arthritis

Psoriatic arthritis

Systemic sclerosis

Sjögren’s syndrome

Osteoarthritis

Crystal arthropathies

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

April 2020 - Volume 79 - 4

Heroes and pillars of rheumatology

Viewpoint

Rheumatoid arthritis

Psoriatic arthritis

Systemic sclerosis

Sjögren’s syndrome

Osteoarthritis

Crystal arthropathies

Letters

Electronic pages

Issue Information